Skip to main content
. Author manuscript; available in PMC: 2017 Feb 2.
Published in final edited form as: Biometrics. 2011 Oct 31;68(2):550–558. doi: 10.1111/j.1541-0420.2011.01693.x

Table 1.

Reported number of successes/trials for each one of the sarcoma subtypes.

Intermediate Prognosis

subtype successes/trials

Leiomyosarcoma 6/28
Liposarcoma 7/29
MFH 3/29
Osteosarcoma 5/26
Synovial 3/20
Angiosarcoma 2/15
MPNST 1/5
Fibrosarcoma 1/12

Good Prognosis
Ewing’s 0/13
Rhabdo 0/2